Biofrontera Ag (BFRA) SEC Filing 6-K Foreign Issuer report for the period ending Monday, May 11, 2020

Biofrontera Ag

CIK: 1712641 Ticker: BFRA

View differences made from one to another to evaluate Biofrontera Ag's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Biofrontera Ag.


Assess how Biofrontera Ag's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Biofrontera Ag's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Material Contracts, Statements, Certifications & more

Biofrontera Ag provided additional information to their SEC Filing as exhibits

Ticker: BFRA
CIK: 1712641
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001493152-20-008193
Submitted to the SEC: Mon May 11 2020 12:06:29 PM EST
Accepted by the SEC: Mon May 11 2020
Period: Monday, May 11, 2020
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: